Defects in the CAPN1 Gene Result in Alterations in Cerebellar Development and Cerebellar Ataxia in Mice and Humans

Yubin Wang(Western University of Health Sciences), Joshua Hersheson(National Hospital for Neurology and Neurosurgery), Dulce Lopez(Western University of Health Sciences), Monia Hammer(National Institutes of Health), Yan Liu(Western University of Health Sciences), Ka-Hung Lee(Western University of Health Sciences), Vanessa Carla Monteiro Pinto(Western University of Health Sciences), Jeff Seinfeld(Western University of Health Sciences), Sarah Wiethoff(Hertie Institute for Clinical Brain Research), Jiandong Sun(Western University of Health Sciences), Rim Amouri(National Institute of Neurology Mongi-Ben Hamida), Fayçal Hentati(National Institute of Neurology Mongi-Ben Hamida), Neema Baudry(Western University of Health Sciences), Jennifer Tran(Western University of Health Sciences), Andrew B. Singleton(National Institutes of Health), Marie Coutelier(École Pratique des Hautes Études), Alexis Brice(Centre National de la Recherche Scientifique), Giovanni Stévanin(Centre National de la Recherche Scientifique), Alexandra Dürr(Pitié-Salpêtrière Hospital), Xiaoning Bi(Western University of Health Sciences), Henry Houlden(University College London), Michel Baudry(Western University of Health Sciences)
Cell Reports
June 1, 2016
Cited by 98Open Access
Full Text

Abstract

A CAPN1 missense mutation in Parson Russell Terrier dogs is associated with spinocerebellar ataxia. We now report that homozygous or heterozygous CAPN1-null mutations in humans result in cerebellar ataxia and limb spasticity in four independent pedigrees. Calpain-1 knockout (KO) mice also exhibit a mild form of ataxia due to abnormal cerebellar development, including enhanced neuronal apoptosis, decreased number of cerebellar granule cells, and altered synaptic transmission. Enhanced apoptosis is due to absence of calpain-1-mediated cleavage of PH domain and leucine-rich repeat protein phosphatase 1 (PHLPP1), which results in inhibition of the Akt pro-survival pathway in developing granule cells. Injection of neonatal mice with the indirect Akt activator, bisperoxovanadium, or crossing calpain-1 KO mice with PHLPP1 KO mice prevented increased postnatal cerebellar granule cell apoptosis and restored granule cell density and motor coordination in adult mice. Thus, mutations in CAPN1 are an additional cause of ataxia in mammals, including humans.


Related Papers

No related papers found

Powered by citation graph analysis